PUBLICATION

Naltrexone Alters Neurochemical and Behavioral Parameters in a Zebrafish Model of Repeated Alcohol Exposure

Authors
Bernardo, H.T., Lodetti, G., de Farias, A.C.S., de Pieri Pickler, K., Baldin, S.L., Dondossola, E.R., Rico, E.P.
ID
ZDB-PUB-250208-9
Date
2025
Source
Neurochemical research   50: 9797 (Journal)
Registered Authors
Keywords
Alcoholism, Naltrexone, Neuroscience, Opioid system, Zebrafish
MeSH Terms
  • Animals
  • Anxiety/drug therapy
  • Anxiety/metabolism
  • Behavior, Animal*/drug effects
  • Dopamine/metabolism
  • Ethanol*/pharmacology
  • Male
  • Naltrexone*/pharmacology
  • Narcotic Antagonists*/pharmacology
  • Serotonin/metabolism
  • Zebrafish*
PubMed
39920352 Full text @ Neurochem. Res.
Abstract
Between the neurotransmission systems modulated by alcohol, the opioid system has been receiving attention in studies that seek to understand its relationship to the effects of addictive substances and different neuropsychiatric disorders. The use of naltrexone stands out in determining the mechanisms of the opioid system, as it acts as an opioid antagonist and consequently generates neurochemical responses. This study aimed to evaluate the pharmacological modulation of opioids on behavioral and neurobiological aspects in adult zebrafish submitted to the protocol of repeated exposure to ethanol and treated with naltrexone. Opioid modulation using naltrexone has been shown to modulate anxiety-like behavior, presenting anxiolytic properties in isolation, in addition to reversing the anxiogenic effect of ethanol through the Novel tank and Light/dark test. Naltrexone increased serotonin and dopamine levels, while ethanol antagonized these effects. In contrast, the interaction between ethanol and naltrexone raised noradrenaline levels. Naltrexone altered glutamate levels, however, ethanol reversed it. Ethanol acted on glutamate transporters increasing their activities, while naltrexone treatment reduced activities. No significant results were found in the pro-oxidant parameters, however, ethanol reduced SOD activity while naltrexone reversed. The same occurred in CAT activity. Also, naltrexone up-regulated the expression of genes related to the dopaminergic, glutamatergic, and opioid systems. The genes used as markers of the inflammatory process and glial activity were modulated by ethanol and together with naltrexone, respectively. Taken together, our findings reinforce the importance of opioid signaling on biochemical and molecular bases related to neuropsychiatric behaviors and diseases, such as anxiety and substance dependence.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping